{"contraindications":["CONTRAINDICATIONS P32 sodium phosphate should not be used in the presence of ulcerative tumors."],"description":["DESCRIPTION AnazaoHealth’s compounded P32 Chromic Phosphate is supplied as a sterile, nonpyrogenic aqueous solution. It contains 30 % dextrose solution, 1 mg sodium acetate, 2 % benzyl alcohol added as a preservative. Sodium hydroxide or hydrochloric acid may be added for pH adjustment."],"dosage_and_administration":["DOSAGE AND ADMINISTRATION Shake the vial well before injection. For intraperitoneal instillation, administer 10-20 mCi For intrapleural instillation, administer 6 to 12 mCi Doses for interstitial use should be based on estimated gram weight of tumor, about 0.1 to 0.5 mCi/gm."],"effective_time":"20120619","id":"5ed86373-1e27-42fc-a3b3-b198944f0dff","indications_and_usage":["INDICATIONS AND USAGE P32 chromic phosphate is indicated for intracavitary instillation for the treatment of peritoneal or pleural effusions caused by metastatic disease, and may be injected interstitially for the treatment of cancer. It is also used in hemophilia patients for intraarticular injections. Mechanism of Action Radioactive phosphorous works by local irradiation by beta emission."],"openfda":{},"package_label_principal_display_panel":["PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Figure 1 5ed86373-figure-01 5ed86373-figure-02"],"set_id":"4996cd1e-4338-43d7-b7aa-418909ab8c16","spl_product_data_elements":["P32 Sodium Phosphate P32 Sodium Phosphate PHOSPHORUS P-32 PHOSPHORUS P-32 DEXTROSE BENZYL ALCOHOL SODIUM ACETATE"],"spl_unclassified_section":["DECAY CHART"],"version":"1","warnings":["WARNINGS Not for intravascular injection."]}